Quoin Pharmaceuticals Ltd ADR QNRX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $4.16
- Day Range
- $4.12–4.13
- 52-Week Range
- $3.48–41.80
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 2.01M
- Market Cap
- $8.52M
- Volume/Avg
- 12,842 / 241,082
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 6
- Website
- https://www.quoinpharma.com
Valuation
|
Metric
|
QNRX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.95 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
QNRX
Financial Strength
|
Metric
|
QNRX
|
|---|---|
Quick Ratio | 2.63 |
Current Ratio | 2.87 |
Interest Coverage | — |
Quick Ratio
QNRX
Profitability
|
Metric
|
QNRX
|
|---|---|
Return on Assets (Normalized) | −124.41% |
Return on Equity (Normalized) | −274.70% |
Return on Invested Capital (Normalized) | −283.00% |
Return on Assets
QNRX
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|?rVT^Z | LOCK|$L&> | $121B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|!>cS>&N | LOCK|gVR?# | $70B | |||
| argenx SE ADR
ARGX
| LOCK|#VbFgtp | LOCK|#W | $54B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|^^jB^v& | LOCK|%Xqs^ | $37B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|#&&sKL | LOCK|%f | $37B | |||
| Moderna Inc
MRNA
| LOCK|C!PRlT> | LOCK|X<& | $27B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|S$!pLkv | LOCK|^G<Y^ | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|#^BbF% | LOCK|c!< | $23B | |||
| Incyte Corp
INCY
| LOCK|p%%Yk?S | LOCK|#y> | $23B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|&!<&C<< | LOCK|FHq | $16B |
United States